Research and analysis

Laboratory reports of hepatitis C infections in England and Wales: January to March 2024

Published 27 February 2025

Applies to England and Wales

Between January and March a total of 3,463 laboratory reports of hepatitis C (HCV) were reported to the UK Health Security Agency (UKHSA).

There was a 4% decrease in the number of reports compared to the first quarter of 2023 (n=3,594).

Since 2017, one laboratory in the North West of England has undertaken HCV dried blood spot testing alongside routine laboratory testing. This single laboratory has taken on testing for a large part of the country. However, some samples where geographical information is lacking, may have been incorrectly assigned to this specific laboratory rather than the laboratory from which the sample originated.

Age and sex were well reported (98% complete). Where sex was known, males accounted for 1% of reports (1,775 out of 3,463), which is higher than previous quarters and years.

Adults aged 35 to 44 years accounted for 28% of the total number of hepatitis C reports.

Table 1. Laboratory reports of hepatitis C in England and Wales, January to March 2024*

Age group Males Females Unknown Total
1 to 4 years 2      0      0      2  
5 to 9 years 0      2      0      2  
10 to 14 years 2      3      0      5  
15 to 24 years 37      28      6      71  
25 to 34 years 260      122      78      460  
35 to 44 years 484      216      262      962  
45 to 54 years 468      175      280      923  
55 to 64 years 292      137      124      553  
≥65 years 211      170      29      410  
Unknown 19      10      46      75  
Total 1,775   863    825    3,463  

*Provisional data

Notes: Individuals aged under 1 year are excluded, since positive tests in this age group may reflect the presence of passively-acquired maternal antibody rather than true infection. Laboratory reports are not reliable for differentiating acute and chronic hepatitis C infections. Laboratory reports include individuals with a positive test for hepatitis C antibody, antigen and/or detection of hepatitis C RNA. A small proportion of these specimens are diagnosed following dried blood spot (DBS) testing, however not all DBS testing is reported by laboratories.

In Table 2, laboratory reports are presented broken down by Operational Delivery Network (ODN). ODNs were launched in July 2013 following the publication of the NHS England strategy to sustain and develop clinical networks.

ODNs are the networks through which hepatitis C treatment is being delivered across England. Between January and March 2024, 2,945 out of 3,463 individuals in England had been allocated to an ODN.

Table 2. Laboratory reports of hepatitis C by Operational Delivery Network, January to March 2024

Primary ODN Total
Barts 153
Birmingham 152
Bristol and Severn 158
Cheshire and Merseyside 146
Eastern Hepatitis Network 121
Greater Manchester and Eastern Cheshire 322
Humberside and North Yorkshire 27
Kent Network via Kings 22
Lancashire and South Cumbria 120
Leicester 116
North Central London 144
North East and Cumbria 185
Nottingham 150
South Thames Hepatitis Network 201
South West Peninsula 39
South Yorkshire 81
Surrey Hepatitis Services 112
Sussex Hepatology Network 60
Thames Valley Hep C ODN 44
Wessex Hep C ODN 126
West London 306
West Yorkshire 160

ODNs are based on NHS England Clinical Commissioning Groups (CCGs) geographic boundaries. NHS England allocates a primary or lead ODN for CCGs which may cross more than one ODN.